BridgeMD
New treatment option for Cough
Official title Validation of the C-mo System - Cough Monitoring
ClinicalTrials.gov ID: NCT05989698
What this study is testing
- What it's testing
- The goal of this clinical study is to validate C-mo System's ability to automatically detect and characterise cough, in patients over 2 years old with cough as a key or refractory symptom. The main questions it aims to answer are: 1.
- Time commitment: about 2 years
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 2 and older
You may be able to join if
- Patients aged 2 years or older;
- Patients with symptoms/complaints of cough;
- Signed Informed Consent (age ≥ 18 years), signed Informed Consent from the parents/legal representative and the patient (16 and 17 years), or signed...
You likely can't join if
- Presence of musculoskeletal (e.g., severe scoliosis), neurological (e.g., post stroke), cardiac (e.g., unstable angina), cognitive (e.g., dementia)...
- Damaged/weakened skin at the C-mo wearable device's placement area (epigastric region).
- Absence of Informed Consent and/or Assent, as applicable.
The study team makes the final eligibility decision.
Where it's taking place
- Alfena, Portugal
- Amadora, Portugal
- Aveiro, Portugal
- Coimbra, Portugal
- Lisbon, Portugal
- Porto, Portugal
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 2 years per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 2 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Alfena, Portugal; Amadora, Portugal; Aveiro, Portugal; Coimbra, Portugal; Lisbon, Portugal; Porto, Portugal. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.